NCT03528707View on ClinicalTrials.gov

Effect of Probiotic Co-administration With Omega-3 Fatty Acids on NAFLD

NACompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

April 14, 2015

Primary Completion Date

December 22, 2015

Study Completion Date

January 28, 2016

Conditions
Type2 DiabetesNAFLDProbioticOmega-3 Fatty Acids
Interventions
DIETARY_SUPPLEMENT

Symbiter-Omega

"Symbiter Omega which contains combination of flax and wheat germ oil (250 mg of each, concentration of omega-3 fatty acids 1-5%), supplemented with biomass of 14 alive probiotic strains: Lactobacillus + Lactococcus (6×1010 CFU/g), Bifidobacterium (1×101"

DIETARY_SUPPLEMENT

Placebo

Over 8 weeks of interventional period, the patient received 1 sachet (10 grams) of gel per day

All Listed Sponsors
lead

Bogomolets National Medical University

OTHER

NCT03528707 - Effect of Probiotic Co-administration With Omega-3 Fatty Acids on NAFLD | Biotech Hunter | Biotech Hunter